KCT0000379招募中未知
Phase 1 and Phase 2 clinical trials for the evaluation of pharmacokinetics, safety, and efficacy of SNUBH-NM-333(18F), a new diagnostic radiopharmaceutical for PET imaging of amyloid plaques, in Alzheimer's disease patients and healthy volunteers
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 60(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •Clinical Dementia Rating: over 0.5
- •NINCDS/ADRDA criteria probable Alzheimer's disease
- •DSM-IV criteria Alzheimer's Disease
排除标准
- •Evidence of delirium or confusion, other consciousness disorder
- •Nuerologic disease that causes cognitive fuction decline(parkinson's disease, stroke, brain hemorrhage, cancer, normal pressure hydrocephalus etc.)
研究者
相似试验
尚未招募
不适用
Phase I / II, Multicenter Clinical trial to evaluate the safe dose range and confirm the effectiveness and safety of the maximum tolerated dose of Docetaxel In combination with SH003 in patients with solid tumor who are indicated for DocetaxelKCT0004770Korea University Anam Hospital110
已完成
1 期
Phase I/II clinical trial to evaluate the efficacy and safety of DFP-17729 in patients with unresectable/recurrent/progressive pancreatic cancerJPRN-UMIN000042064Delta-Fly Pharma, Inc.39
已完成
1 期
Phase I /II and Pharmacological Clinical Study of Combination Chemotherapy with Irinotecan(CPT-11) and Erlotinib(Tarceva) for Recurrent Lung Cancerrecurrent non small cell lung cancer after chemotherapyJPRN-UMIN000004639Shimane university hospital45
进行中（未招募）
1 期
Clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with phosphomannomutase deficiency.Cerebellar syndromeMedDRA version: 19.1Level: PTClassification code 10008072Term: Cerebellar syndromeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-000810-44-ESFundació Sant Joan de Déu30
招募中
1 期
Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E to castration resistant prostate cancer patientsCastration resistant prostate cancerJPRN-UMIN000006142Department of Urology, Osaka University Graduate School of Medicine12